Hope for Parkinson’s disease symptoms is found in late-stage drug study
Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...
AbbVie's Parkinson's disease drug improves patient mobility in late-stage study
AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...
This Drugmaker's (ABBV) Parkinson's Medication Just Cleared A Key Hurdle – Is It Primed ...
Meta-Description: Drugmaker AbbVie could be set up for a big year in 2025 after completing another successful clinical trial ...
National Institute for Health and Care Excellence7 天
MRI-guided focused ultrasound subthalamotomy for treating Parkinson’s
People with Parkinson's classically present with the symptoms and signs described as 'parkinsonism'. These include bradykinesia (slow movements), rigidity, rest tremor (shaking) and postural ...
Joplin Globe6 天
Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible ...
Clinical diagnosis of Parkinson’s disease is late in the disease course and currently based only on motor symptoms, with non-motor symptoms often preceding diagnosis by up to 20 years. Prothena ...
manilatimes6 天
Roche's Phase IIb study of prasinezumab missed primary endpoint, but suggests possible ...
About the PADOVA study PADOVA is a Phase IIb multicentre, randomised, double-blind trial evaluating the efficacy and safety of prasinezumab compared with placebo in 586 randomised patients with ...